Park Square is pleased to announce the placement of Martin Vazquez as Chief Operating Officer at Outset Medical.
Outset Medical, a commercial-stage company delivering new technology into the $13 billion global dialysis market, today announced the...…
Despite a promising approach for certain leukemia patients, the path to market appears to be in question.
The therapy was developed at the National Cancer Institute, and Dr. Mackall said researchers did not know if a company would try to bring...…
Park Square has placed Jim Glasheen as executive vice chancellor, innovation & business development at UMass Medical School.
Jim Glasheen, PhD, a prominent venture capitalist in the biopharmaceutical, medical technology and patient-centered health fields, will...…
Exciting leadership developments at Melinta!
The board will also be comprised of former board members from Melinta and Cempra as well as the addition of Jay Galeota, a pharmaceutical...…
Melinta Therapeutics, Inc., a privately held company developing and commercializing novel antibiotics to treat serious bacterial...…
Park Square places Robert Nagle as Chief Technology Officer and Chief Product Officer.
Interactions, LLC, a leading provider of Intelligent Virtual Assistants (IVAs) for enterprise customer care, today announced Robert Nagle...…
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net